Neos Therapeutics Inc. (NASDAQ: NEOS) flaunted slowness of -4.93% at $0.80, as the Stock market unbolted on March 03, 2021. During the day, the stock rose to $0.868 and sunk to $0.8024 before settling in for the price of $0.84 at the close. Taking a more long-term approach, NEOS posted a 52-week range of $0.45-$1.54.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 143.30%. Meanwhile, its Annual Earning per share during the time was 28.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 78.80%. This publicly-traded company’s shares outstanding now amounts to $49.76 million, simultaneously with a float of $49.22 million. The organization now has a market capitalization sitting at $42.20 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8430, while the 200-day Moving Average is $0.7143.
If we measure the efficiency of the company that is accounted for 213 employees. It has generated 303,516 per worker during the last fiscal year. Meanwhile, its income per employee was -79,352. The stock had 2.38 Receivables turnover and 0.64 Total Asset turnover. For the Profitability, stocks gross margin was +61.14, operating margin was -16.11 and Pretax Margin of -26.13.
Neos Therapeutics Inc. (NEOS) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Neos Therapeutics Inc. industry. Neos Therapeutics Inc.’s current insider ownership accounts for 1.50%, in contrast to 21.10% institutional ownership.
Neos Therapeutics Inc. (NEOS) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2020, it has been observed that the corporation posted -$0.1 earnings per share (EPS) during the time that was less the consensus figure (set at -$0.05) by -$0.05. This company achieved a net margin of -26.14 while generating a return on equity of -1,971.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Neos Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 78.80% and is forecasted to reach -0.06 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 31.70% through the next 5 years, which can be compared against the 28.10% growth it accomplished over the previous five years trading on the market.
Neos Therapeutics Inc. (NASDAQ: NEOS) Trading Performance Indicators
Let’s observe the current performance indicators for Neos Therapeutics Inc. (NEOS). It’s Quick Ratio in the last reported quarter now stands at 0.50. The Stock has managed to achieve an average true range (ATR) of 0.11. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.74.
In the same vein, NEOS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.44, a figure that is expected to reach 0.00 in the next quarter, and analysts are predicting that it will be -0.06 at the market close of one year from today.
Technical Analysis of Neos Therapeutics Inc. (NEOS)
Now, what If we examine the latest scores posted by [Neos Therapeutics Inc., NEOS]. During the last 5-days, its volume was lower the volume of 4.96 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 17.76% While, its Average True Range was 0.1053.
Raw Stochastic average of Neos Therapeutics Inc. (NEOS) in the period of the previous 100 days is set at 37.64%, which indicates a major rise in contrast to 5.24% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 87.61% that was lower than 121.35% volatility it exhibited in the past 100-days period.